Return to homepagePandemic Pact

Neurological involvement in clinically relevant Covid-19 disease. Does Neuro-Covid-19 disease exist?

  • Funded by National Institute of Health Carlos III [El Instituto de Salud Carlos III] (ISCIII)
  • Total publications:0 publications

Grant number: COV20_00157

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    N/A

  • Funder

    National Institute of Health Carlos III [El Instituto de Salud Carlos III] (ISCIII)

  • Principal Investigator

    Pedro Jesus Serrano Castro, Fernando Rodriguez de Fonseca

  • Research Location

    Spain

  • Lead Research Institution

    FUNDACION PARA LA INVESTIGACION DE MALAGA EN BIOMEDICINA Y SALUD (FIMABIS)

  • Research Priority Alignment

    N/A

  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Disease pathogenesis

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Not applicable

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

1]. On the other hand, in a retrospective review of 214 cases assisted during the epidemic outbreak in Wuhan, symptoms attributable to both the CNS and the PNS are described in a relevant percentage (Mao L et al MedRxiv 2020.02.22.20026500). Based on these data, we establish the hypothesis that neurological involvement in the acute phase and in the medium or long term may condition the prognosis and quality of life in patients surviving the infection. The objective of this project is the clinical, biological and molecular characterization of neurological involvement in a prospective cohort of patients surviving SARS-CoV-2 infection.